May 3, 2024 05:00PM
Jan 18, 2024 06:05PM
Jan 18, 2024 05:49PM
Jan 4, 2024 08:01AM
Jan 4, 2024 08:00AM
Nov 9, 2023 04:05PM
Sep 12, 2023 04:05PM Eiger BioPharmaceuticals (EIGR) to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda
Sep 12, 2023 04:05PM
Sep 5, 2023 04:05PM
Aug 14, 2023 04:05PM
Jun 29, 2023 08:07AM
Jun 29, 2023 08:00AM
May 11, 2023 04:00PM
May 3, 2023 04:05PM Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Apr 13, 2023 08:00AM
Mar 16, 2023 04:28PM
Feb 8, 2023 05:00PM
Feb 8, 2023 05:00PM
Jan 3, 2023 09:00PM
Dec 28, 2022 09:03PM
Dec 23, 2022 09:07PM EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Dec 16, 2022 10:53PM
Dec 16, 2022 05:46AM
Dec 15, 2022 05:45PM
Dec 12, 2022 11:01PM
Dec 8, 2022 08:06AM
Dec 8, 2022 08:00AM
Dec 7, 2022 08:57PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent the Runway and Encourages Investors to Contact the Firm
Dec 7, 2022 04:05PM
Dec 5, 2022 12:07PM
Nov 8, 2022 04:05PM
Nov 3, 2022 04:01PM
Oct 24, 2022 04:05PM
Oct 11, 2022 08:00AM
Oct 5, 2022 08:03AM Eiger BioPharmaceuticals (EIGR) will not submit EUA application of peginterferon lambda for treatment of patients with mild-to-moderate COVID-19
Oct 5, 2022 08:00AM
Sep 22, 2022 08:00AM
Sep 6, 2022 08:04AM
Sep 6, 2022 08:00AM
Sep 1, 2022 08:00AM
Aug 4, 2022 04:05PM
Jul 28, 2022 08:00AM Eiger BioPharmaceuticals to Host Conference Call for Second Quarter 2022 Financial Results and Business Update on Thursday, August 4
Jul 20, 2022 08:01AM
Jul 20, 2022 08:00AM
Jul 18, 2022 08:00AM
Jun 27, 2022 04:05PM
Jun 13, 2022 08:10AM
Jun 13, 2022 08:00AM
Jun 8, 2022 08:00AM Eiger BioPharmaceuticals Announces Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022
Jun 7, 2022 04:06PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All